Ann Barber is a Managing Director at Hall Capital Partners LLC in the Public Equity group, responsible for research, identification, due diligence, and monitoring of long-only public equity investments and long-short equity hedge funds. She is also a Portfolio Manager for several family, and endowment and foundation clients. Barber is also a member of Medicines360’s Investment Review Committee.
Prior to joining the firm in 2006, Ms. Barber spent several years at Lazard Asset Management in New York where she consulted on a number of strategic projects, and researched Japanese financial stocks. Previously, she was a Senior Research Analyst covering health care equities at Montgomery Asset Management, Credit Suisse-First Boston, Cowen & Co., and Prudential Securities. She began her financial career at Prudential Securities in investment banking, prior to transferring into the equity research emerging analyst program.
Ms. Barber is a member of the Board of Directors of both the UCSF Foundation Investment Company and Medicines360, a global non-profit women’s health pharmaceutical company. She also serves on the Investment Committee for the Marin Community Foundation. Previously, Ms. Barber served on the Investment Committee for both the San Francisco Day School and Gateway Schools in San Francisco, and was a member of the Bay Area Board of Directors for Reading Partners, a non-profit devoted to promoting literacy in public schools.
Ms. Barber graduated with honors from the University of Wisconsin at Madison with a B.A. in Economics, International Relations and Spanish. She also earned an M.A. from the School of Advanced International Studies (SAIS) of The Johns Hopkins University, and an M.B.A. from the Wharton School of the University of Pennsylvania.